NCEL
NewcelX Ltd.
NASDAQ · Healthcare · Biotechnology · CH
$3.34
−0.30%Jul 31, 2026, 13:00 UTC
NewcelX priced a $1.4 million private equity financing at a 20% premium to support its lead Type 1 Diabetes program.
Source:
NASDAQ · Healthcare · Biotechnology · CH
Jul 31, 2026, 13:00 UTC